Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

SHTG Innovative Medical Technology Overview

  • Home
  • Our Advice
  • The SARUS (safer - airway - resuscitation) - CPR hood™ to protect first responders from biohazards

Title

Output Type

Speciality

Published

Title

The SARUS (safer - airway - resuscitation) - CPR hood™ to protect first responders from biohazards

Output Type

SHTG Innovative Medical Technology Overview

Speciality

Ear, nose and throat, Respiratory system, Infectious disease, COVID-19

Published

29 October 2021

Key findings

A small, unpublished randomised crossover trial, found that the technical tasks of performing cardiopulmonary resuscitation (CPR) using a manikin were conducted equally well with the SARUS-CPR hoodTM employed when compared with the use of standard CPR equipment. The time taken to complete the first three chest compressions was longer when using the SARUS-CPR hoodTM (63 seconds compared with 42 seconds for standard CPR equipment).

In unpublished experiments using aerosol particles, less than 1% of particle concentration was detected at the breathing zone of the resuscitator. This may indicate protection from aerosol-borne viral and bacterial infections. The SARUS-CPR hoodTM also offers protection from contamination of skin and eyes by large coughed droplets, saliva, blood and vomitus.

Potential safety issues associated with the use of the SARUS-CPR hoodTM include reduction in internal jugular venous outflow and the risk of emotional distress to the patient in regaining consciousness within the confining  SARUS-CPR hoodTM.

Further assessment relating to the efficacy, safety, ease of use and clinical impact of the device under intended conditions of use is required.

What were we asked to look at?

We were asked to provide a high level overview of the SARUS-CPR hoodTM  which is a single use containment/exposure-control device designed to improve safety for personnel and patients during traditional ‘bag and mask’ ventilation. The technology is used as part of CPR by Basic Life Support (BLS)-trained responders.

Why is this important?

A cardiac arrest occurs when the heart stops pumping blood around the body, commonly because of a problem with the electrical signals in a person's heart. CPR can be a lifesaving procedure for people whose heart has stopped. However, performing CPR may put the rescuer at risk of infection by breathing in particles from the patient or by coming into contact with body fluids including blood, saliva and vomit.

The SARUS-CPR hoodTM can be slipped over the head of the person and secured so that rescuers are able to quickly start CPR procedures and be protected from possible infections.

Referred by 

The developers of SARUS-CPR hoodTM requested SHTG to assess the evidence for its use.

 

Download icon
Download Advice
pdf (768 KB)
Download icon
Download Plain language summary
pdf (576 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?